PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Indonesia University
Wake Forest University Health Sciences
National Cancer Institute (NCI)